FXR

nwamba # Aha ngwaahịa Nkọwa
CPD9470 Obeticolic acid Obeticholic acid (INT747; 6-ECDCA) bụ akwụkwọ akụkọ ewepụtara nke cholic acid nke na-arụ ọrụ dị ka FXR agonist nwere ike ma họrọ nke na-egosipụta ọrụ anticholeretic na ụdị vivo oke nke cholestasis. Ọ na-egbochi vaskụla ire ụtọ mkpụrụ ndụ mbufụt na mbugharị yana na-akwalite ọdịiche adipocyte ma na-achịkwa ọrụ adipose cell na vivo.
CPD100579 fexaramine Fexaramine bụ agonist nke farnesoid X receptor (FXR), nke bụ bile acid na-arụ ọrụ nuklia nke na-achịkwa njikọ bile-acid, njikọ na njem, yana metabolism lipid site na imeju na eriri afọ. Fexaramine nwere 100-fold ukwuu mmekọrịta maka FXR karịa eke ogige ma kọwaa genomic lekwasịrị anya na njikọ saịtị na FXR. Mgbe a na-enye ụmụ oke ọnụ ọnụ, fexaramine mepụtara omume nhọrọ site na ndị na-anabata FXR na eriri afọ.
CPD100577 Lithocholic acid Levallorphan, makwaara dị ka levallorphan tartate (USAN), bụ onye modulator opioid nke ezinụlọ morphin na-eji dị ka opioid analgesic na opioid antagonist/antidote. Ọ na-eme dị ka onye na-emegide μ-opioid receptor (MOR) na dị ka agonist nke κ-opioid receptor (KOR), na n'ihi ya, na-egbochi mmetụta nke ndị ọrụ siri ike na-arụ ọrụ dị ukwuu dị ka morphine ebe n'otu oge na-emepụta analgesia. . Dị ka agonist nke KOR, levallorphan nwere ike iwepụta mmeghachi omume uche siri ike na usoro zuru oke gụnyere ịhụ anya, dissociation, na mmetụta psychotomimetic ndị ọzọ, dysphoria, nchekasị, mgbagwoju anya, dizziness, disorientation, dealization, mmetụta nke ịṅụbiga mmanya ókè, na ihe jọgburu onwe ya, pụrụ iche, ma ọ bụ na-akpasu nrọ nrọ. . (Isi mmalite: https://en.wikipedia.org/wiki/Levallorphan).
CPD100575 Turofexorate - isoropyl Turofexorate isopropyl, nke a makwaara dị ka WAY-362450 na XL335, bụ nnukwu ike, nhọrọ, na onye na-arụ ọrụ agonist nke farnesoid X receptor (FXR) (EC (50) = 4 nM, Eff = 149%), nke na-eme ka ọnya imeju na-ebelata. na fibrosis na ụdị murine nke steatohepatitis na-abụghị mmanya
CPD100574 GW4064 GW4064是一种farnesoid X receptor (FXR)激动剂,CV1细胞系中EC50为65 nM。
CPD1549 Ọgwụgwọ nke Tropifexor Tropifexor bụ akwụkwọ akụkọ na nnukwu ike agonist nke FXR nwere EC50 nke 0.2 nM.
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

  • Usoro 7 kachasị na nyocha ọgwụ na 2018

    Usoro 7 kacha elu na nyocha ọgwụ m...

    N'ịbụ ndị nọ n'okpuru nrụgide na-arịwanye elu mgbe niile ịsọ mpi na gburugburu ebe obibi akụ na ụba na nkà na ụzụ siri ike, ụlọ ọrụ ọgwụ na biotech ga-anọgide na-emepe emepe na mmemme R&D ha iji nọgide na-aga n'ihu ...

  • ARS-1620: Onye mmechi ọhụrụ na-ekwe nkwa maka ọrịa cancer KRAS-mutant

    ARS-1620: ihe mgbochi ọhụrụ na-ekwe nkwa maka K…

    Dị ka otu nnyocha e bipụtara na Cell si kwuo, ndị nchọpụta ewepụtala ihe mgbochi kpọmkwem maka KRASG12C nke a na-akpọ ARS-1602 nke na-eme ka ụbụrụ tumor regression na ụmụ oke. "Ọmụmụ ihe a na-enye na vivo ihe akaebe na mutant KRAS nwere ike ịbụ ...

  • AstraZeneca na-enweta nkwalite nchịkwa maka ọgwụ oncology

    AstraZeneca na-enweta nkwalite nchịkwa maka ...

    AstraZeneca nwetara nkwalite okpukpu abụọ maka pọtụfoliyo oncology ya na Tuesday, mgbe ndị na-ahụ maka US na European nabatara ntinye iwu maka ọgwụ ya, nzọụkwụ mbụ iji nweta nkwado maka ọgwụ ndị a. ...

Mkparịta ụka WhatsApp n'ịntanetị!